| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.994 | 17.797 | 20.148 | 47.317 | 74.744 | 31.585 | 27.305 | 23.973 | 23.967 | 16.424 |
| Total Income - EUR | 18.994 | 17.797 | 20.148 | 47.317 | 74.744 | 31.585 | 27.305 | 23.973 | 23.968 | 16.425 |
| Total Expenses - EUR | 18.474 | 15.463 | 13.021 | 17.052 | 6.172 | 5.235 | 4.482 | 7.662 | 5.126 | 5.498 |
| Gross Profit/Loss - EUR | 519 | 2.333 | 7.127 | 30.265 | 68.572 | 26.350 | 22.822 | 16.312 | 18.842 | 10.927 |
| Net Profit/Loss - EUR | -51 | 1.799 | 6.522 | 28.846 | 66.329 | 25.471 | 22.004 | 15.607 | 15.669 | 9.016 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Asklepion - Cardiologie - Terapia Durerii Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.079 | 11.640 | 5.728 | 578 | 209 | 0 | 0 | 0 | 0 | 622 |
| Current Assets | 24.933 | 21.150 | 32.994 | 61.189 | 127.000 | 142.722 | 98.702 | 17.514 | 16.052 | 9.696 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11.828 | 17.957 | 23.410 | 34.998 | 55.161 | 70.660 | 82.296 | 16.440 | 12.090 | 7.500 |
| Cash | 4.106 | 3.193 | 9.584 | 26.191 | 71.839 | 72.062 | 16.406 | 1.075 | 3.962 | 2.197 |
| Shareholders Funds | 43.088 | 32.524 | 38.495 | 60.979 | 126.128 | 141.809 | 96.831 | 15.655 | 15.717 | 9.064 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 924 | 266 | 282 | 832 | 1.130 | 913 | 1.908 | 1.859 | 376 | 1.254 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Asklepion - Cardiologie - Terapia Durerii Srl